ABCG2 p.Arg309Gly

Predicted by SNAP2: A: N (61%), C: N (53%), D: D (59%), E: N (72%), F: D (63%), G: N (53%), H: N (82%), I: N (66%), K: N (93%), L: N (66%), M: N (57%), N: N (78%), P: N (53%), Q: N (82%), S: N (72%), T: N (78%), V: N (61%), W: D (66%), Y: D (59%),
Predicted by PROVEAN: A: N, C: D, D: N, E: N, F: D, G: N, H: N, I: D, K: N, L: D, M: N, N: N, P: D, Q: N, S: N, T: N, V: D, W: D, Y: D,

[switch to compact view]
Comments [show]
Publications
[hide] Kage K, Tsukahara S, Sugiyama T, Asada S, Ishikawa E, Tsuruo T, Sugimoto Y
Dominant-negative inhibition of breast cancer resistance protein as drug efflux pump through the inhibition of S-S dependent homodimerization.
Int J Cancer. 2002 Feb 10;97(5):626-30., 2002-02-10 [PMID:11807788] [PubMed]

Abstract [show]
Comments [show]
Sentences [show]

[hide] Li YF, Polgar O, Okada M, Esser L, Bates SE, Xia D
Towards understanding the mechanism of action of the multidrug resistance-linked half-ABC transporter ABCG2: a molecular modeling study.
J Mol Graph Model. 2007 Mar;25(6):837-51. Epub 2006 Aug 30., [PMID:17027309] [PubMed]

Abstract [show]
Comments [show]
Sentences [show]